SPDR Kensho Final Frontiers ETF vs Tempus AI — how do they compare? SPDR Kensho Final Frontiers ETF trades at $102.84 (market cap $176.19M), while Tempus AI trades at $70 (market cap $12.77B). The key difference: Tempus AI is far larger — about 72.5× SPDR Kensho Final Frontiers ETF's market cap, and SPDR Kensho Final Frontiers ETF is more actively traded (34,479 versus 8,980,490). Which is the better fit depends on your goals — on Pluang, investors hold SPDR Kensho Final Frontiers ETF for 8 Days and Tempus AI for 22 Days on average.
| ROKT | TEM | |
|---|---|---|
Market Cap | $176.19M | $12.77B |
Volume | 34,479 | 8,980,490 |
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $136.68 | $99.28 |
52-Week Low | $72.93 | $41.55 |
Typical Hold Time | 8 Days | 22 Days |
Enterprise Value | — | $13.40B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.
Read more on ROKT →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →